Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	303.02	315.35	386.19	200.84	86.47	183.88
Cash & Short-Term Investments	303.02	315.35	386.19	200.84	86.47	183.88
Cash Growth	-4.00%	-18.34%	92.29%	132.26%	-52.97%	-16.41%
Receivables	198.83	142	94.82	37.7	-	-
Inventory	18.44	15.73	15.14	4.32	-	-
Prepaid Expenses	16.34	11.98	8.12	2.78	0.05	0.15
Total Current Assets	536.62	485.06	504.26	245.64	86.52	184.02
Property, Plant & Equipment	23.14	5.97	7.62	1.14	0.94	1.79
Goodwill	12.04	12.04	12.04	10.31	-	-
Other Intangible Assets	43.73	46.89	53.29	59.66	-	-
Other Long-Term Assets	24.25	18.53	11.03	14.72	0.32	0.32
Total Assets	639.79	568.5	588.24	331.48	87.79	186.13
Accounts Payable	91.63	72	40.68	38.61	13.15	13.5
Accrued Expenses	168.89	145.61	90.5	51.63	9.3	8.71
Short-Term Debt	70	-	-	-	-	-
Current Portion of Leases	2.35	3.26	1.27	0.43	0.62	1.22
Current Income Taxes Payable	-	0.96	-	-	-	-
Other Current Liabilities	9.23	8.29	6.41	5.9	-	-
Total Current Liabilities	342.1	230.1	138.85	96.56	23.07	23.44
Long-Term Debt	117.54	180.71	178.07	94.26	49.09	48.32
Long-Term Leases	27.42	8.99	7.04	-	-	0.58
Other Long-Term Liabilities	79.66	91.68	73.3	31.1	-	-
Total Liabilities	566.71	511.48	397.26	221.92	72.15	72.34
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	1,303	1,180	1,027	705.89	424.83	392.59
Retained Earnings	-1,230	-1,123	-835.57	-596.33	-409.2	-278.8
Shareholders' Equity	73.08	57.02	190.98	109.56	15.63	113.79
Total Liabilities & Equity	639.79	568.5	588.24	331.48	87.79	186.13
Total Debt	217.31	192.96	186.37	94.68	49.71	50.12
Net Cash (Debt)	85.71	122.4	199.82	106.16	36.76	133.75
Net Cash Growth	-30.80%	-38.75%	88.23%	188.77%	-72.51%	-33.13%
Net Cash Per Share	1.76	2.55	4.40	2.61	0.98	3.59
Filing Date Shares Outstanding	49.9	48.77	47.37	43.52	38.48	37.41
Total Common Shares Outstanding	49.82	48.67	47.35	43.5	37.82	37.37
Working Capital	194.52	254.96	365.41	149.08	63.45	160.59
Book Value Per Share	1.47	1.17	4.03	2.52	0.41	3.04
Tangible Book Value	17.3	-1.92	125.65	39.59	15.63	113.79
Tangible Book Value Per Share	0.35	-0.04	2.65	0.91	0.41	3.04

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q